Qiagen NV Analyzes Dividend History and Volatility
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 21 2026
0mins
Source: NASDAQ.COM
- Dividend Expectation Analysis: Qiagen NV's recent dividend history suggests a potential annualized yield of 0.5%, contingent on the company's profitability fluctuations, prompting investors to carefully assess the sustainability of future dividends.
- Volatility Calculation: With a trailing twelve-month volatility of 30% based on the last 251 trading days' closing prices, Qiagen NV provides crucial risk assessment insights for investors when selecting options strategies.
- Options Trading Dynamics: On Wednesday, the put volume among S&P 500 components reached 917,392 contracts, while call volume hit 2.14 million, indicating a strong preference for call options among investors, reflecting optimistic market sentiment.
- Options Market Trends: The current put-to-call ratio stands at 0.43, significantly lower than the long-term median of 0.65, indicating a strong bullish outlook among investors as they favor call contracts in options trading.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy QGEN?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on QGEN
Wall Street analysts forecast QGEN stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for QGEN is 50.57 USD with a low forecast of 45.00 USD and a high forecast of 55.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
14 Analyst Rating
8 Buy
6 Hold
0 Sell
Moderate Buy
Current: 53.710
Low
45.00
Averages
50.57
High
55.00
Current: 53.710
Low
45.00
Averages
50.57
High
55.00
About QGEN
Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Intel's Earnings Disappointment Leads to 17% Stock Drop
- Intel Earnings Miss: Intel reported a net loss of $333 million for the last quarter, worse than expected, leading to a more than 17% drop in stock price on Friday, reflecting investor disappointment in the company's future outlook.
- Nutrition Sales Decline: Abbott's nutrition sales fell by 8.9% due to lower volumes and strategic pricing adjustments, resulting in a roughly 13.8% decline in stock price over the past week, indicating market concerns about its growth prospects.
- Qiagen Strategic Options: Qiagen shares surged over 13% last week following reports that the company is exploring strategic options, including a potential sale, signaling positive market expectations for its future development.
- Strong Demand for AMD: AMD's stock rose approximately 9.7% last week, driven by robust demand for artificial intelligence, with analysts expecting better results and higher guidance in its upcoming earnings report, reflecting confidence in its growth potential.
Continue Reading
US Stocks Rise with Nasdaq Up 0.76% Amid Economic Optimism
- Positive Economic Data: Weekly initial jobless claims rose by 1,000 to 200,000, beating expectations of 209,000, indicating labor market resilience and boosting investor confidence in economic recovery.
- GDP Revision Upward: Q3 GDP growth was revised up by 0.1% to an annualized rate of 4.4%, surpassing the expected 4.3%, suggesting strong economic momentum that could further propel stock market gains.
- Surge in Natural Gas Prices: Natural gas prices rose over 3% to a three-year high due to an Arctic cold front increasing heating demand, which is expected to boost related stocks and invigorate the market.
- Strong Performance in Tech Stocks: The Magnificent Seven tech stocks saw significant gains, with Meta and Tesla rising over 5% and 4% respectively, reflecting strong market confidence in technology stocks that may lead the overall market higher.
Continue Reading